PD-1 immunotherapy can eliminate the need for surgery in patients with early-stage solid cancers – AACR AACR shared a post on X: “PD-1 immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers, according to results presented by Andrea Cercek.” More posts featuring AACR. Blog Posts AACR Andrea Cercek cancer early-stage solid cancers fight against cancer Global fight against cancer OncoDaily Oncology PD-1 immunotherapy
